Navigation Links
MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
Date:2/3/2009

are services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. For more information visit www.astrazeneca.com

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to the collaboration between MAP Pharmaceuticals and AstraZeneca. Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, risks and uncertainties relating to the following: regulatory review and approval of UDB; the conduct and timing of clinical trials; the availability, pricing and marketing of competitive products, including generic products; any inability to realize all of the anticipated benefits of the development and commercialization arrangement fully or on the anticipated timeline; a downturn in the pharmaceutical industry; unexpected variations in market growth and demand for pediatric asthma products; or the effect of political or economic instability internationally on the sales or production of UDB. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q, filed with the SEC on November 13, 2008, and available at

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... (PRWEB) September 17, 2014 Recently, BamboofloorChina.com, ... added a new assortment of strand woven bamboo ... it has launched a big promotion for the new ... off. , Autumn is a great shopping season. ... items for old and new customers. All practical items ...
(Date:9/16/2014)... A nice seat cover is necessary for those who want ... offered by Lseat.com have every item clients need to completely ... protected from everyday wear and tear. , Today, the ... seat covers and launched an autumn special offer. All ... fabric that is both washable and breathable. That brings a ...
(Date:9/16/2014)... Marybeth Cale, owner of Cale Communications , ... in the small village of Rhinebeck, New York, has announced ... a mompreneur, has expanded the business to incorporate a new ... maximize potential. Those services will include group trainings and workshops ... coaching for clients all over the country. , Workshops ...
(Date:9/16/2014)... Retinol is favored by a majority of dermatologists ... has so many benefits - it is one of those ... Sublime Beauty . "Healthy skin is our goal, and ... Beauty® Retinol Serum with Vitamin C is a non-irritating, silky ... The Retinol Serum with Vitamin C is now ...
(Date:9/16/2014)... 2014 Operation Smile was founded “on the ... a facial deformity.” To spread their message and mission, the ... at the Beverly Wilshire Hotel in Beverly Hills, California. The ... whose lives have been forever transformed by the efforts of ... with Operation Smile,” said Lynda Erkiletian, Executive Director of The ...
Breaking Medicine News(10 mins):Health News:BamboofloorChina.com Announces Its Promotion For Strand Woven Bamboo Floors 2Health News:Lseat.com: 2006-2014 Chevrolet Tahoe Chevrolet Tahoe Leather Seat Covers At Discounted Rates 2Health News:Mompreneur Marybeth Cale of Cale Communications Announces Launch Of Life Coaching And Workshop Business 2Health News:Retinol, the Gold Standard in Skin Care, Available in a Serum with Vitamin C from Sublime Beauty®; Now 30% Off 2Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2
... 10-30 minutes a day showed significant improvement in social ... Just 10 minutes to 30 minutes of exercise a ... overweight or obese women, American researchers suggest. , ... who took part in the Dose Response to Exercise ...
... can modestly increase the amount of physical activity among ... the Trial of Activity for Adolescent Girls (TAAG), a ... Heart, Lung, and Blood Institute (NHLBI) of the National ... the article, "Promoting Physical Activity in Middle School Girls," ...
... picture of events that underlie the functions of a ... by Cell Press in the journal Molecular Cell, shows ... clock keeps time and may enhance our understanding of ... , A variety of organisms have evolved endogenous timing ...
... 13 Cuyahoga Community College will,celebrate the grand opening ... from 9 a.m. -- noon at the Western Campus, ... -- 9:45 a.m. in the HTC,and building tours will ... 25,000-square-feet, the new Health Technologies Center,includes four classrooms, six ...
... outreach efforts, experts say , , THURSDAY, March 13 (HealthDay ... warning signs of eye diseases that could blind them ... survey shows. , The telephone survey, released Thursday by ... International Foundation, included interviews conducted with 3,000 adults between ...
... -,Best of Show, award winners and ,New and Notables, announced at the ... Aesthetics ... Conference and Expo-, LOS ANGELES, March 13 An ... Los Angeles Spa & Resort,Expo and Conference and Medical Aesthetics Conference and ...
Cached Medicine News:Health News:Minimal Exercise Benefits Overweight Postmenopausal Women 2Health News:After-school programs can increase physical activity of adolescent girls 2Health News:New research provides dynamic visualization of simplest circadian clock 2Health News:Tri-C to Celebrate Health Technologies Center Grand Opening April 4 2Health News:Survey Finds Many Americans Clueless About Eye Disease 2Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 2Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 3Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 4Health News:'Best of Show' Awards Go to Spa and Medical Aesthetics Industry Stars 5
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... product to receive formal designation as a "Promising Innovative ... Scheme" (EAMS) launched in the UK in April 2014. ... process for early access approval under the EAMS.  ...
(Date:9/16/2014)... CorMedix Inc. ("CorMedix") (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... and restatement of its outstanding Series C-2, C-3, ... as well as the warrants issued in its ... remove anti-dilution, price reset and certain change of ...
(Date:9/16/2014)... 16, 2014 Imprimis Pharmaceuticals, Inc. (Nasdaq: ... delivering high quality and novel medicines to physicians and ... Officer Mark Baum will be a presenter ... Conference in New York City.  Mr. Baum will discuss ... campaign in ophthalmology. The presentation is scheduled for 10:40 ...
Breaking Medicine Technology:NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... against cancers and infectious diseases, announced today the publication ... Vaccines detailing potent immune responses in a preclinical ... targeting two antigens. While current prostate cancer therapies target ...
... Feb. 1, 2011 Anthera Pharmaceuticals, Inc. (Nasdaq: ... treat serious diseases associated with abnormal auto-immune responses and ... Thompson to its Board of Directors. Currently, Dr. Thompson ... founder and Managing Director of Strategicon Partners, an investment ...
Cached Medicine Technology:Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 2Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 3Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 4Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial 5Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors 2
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Curved with catch....
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medium weight bone cutter....
Medicine Products: